| Financial Year |
March 31 2023 |
| Monetary Funds |
224,891,008.37 |
| Held-for-trading Financial Assets |
231,893,998.95 |
| Notes Receivable |
-- |
| Accounts Receivable |
144,571,326.97 |
| Advances to Suppliers |
3,362,242.78 |
| Other Receivables |
1,652,762.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
49,653,809.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,407,409.87 |
| Total Current Assets |
718,121,809.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
198,558,278.99 |
| Under-construction Projects |
36,875,382.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,126,098.56 |
| R&D expenses |
-- |
| Goodwill |
2,400,721.28 |
| Long-Term Deferred and Prepaid Expenses |
9,063,222.36 |
| Deferred Income Tax Assets |
2,533,354.44 |
| Other Non-Current Assets |
7,493,990.00 |
| Sub-Total of Non-Current Assets |
296,738,120.16 |
| Total Assets |
1,014,859,929.41 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,400,477.91 |
| Accounts Payable |
31,641,456.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,969,370.36 |
| Taxes Payable |
3,612,797.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,606,968.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
42,441,733.93 |
| Sub-Total of Current Liabilities |
87,752,066.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,089,829.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,617,941.42 |
| Total Liabilities |
118,370,007.95 |
| Paid-In Capital(Or Share Stock) |
75,200,000.00 |
| Capital Surplus |
587,131,776.71 |
| Surplus Reserve |
31,161,213.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
202,996,930.89 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
896,489,921.46 |
| Owner's Equity（Stockholder's Equity） |
896,489,921.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,014,859,929.41 |
